Dewaxed the intestinal tissues using xylene for 10 min and through 90 % , 70 % alcohol and water, tissues were then rehydrated serially in each 7 4 for 5 min. Then after, each slides get dipped in citrate buffer and proceded for antigen retrieval by using EZ Retrieval System V.3 (Bio Genex).
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Sections were washed two times with PBS for 10 min each, and then blocked with 0.1% Triton X-100, 0.1% BSA, 10% FCS, 0.1% sodium 7 6 deoxycholate and 0.02% Thiomersal (anti-fungal agent) in 1X PBS for 2 h at room temperature (RT). All sections were then incubated overnight 7 7 with the primary antibodies at 4°C and then washed with PBST (0.1% triton X in 1XPBS) thrice for 10 min each, followed by incubating each 7 8 sections with anti-rabbit-AF 546 (Red) (Invitrogen, USA) secondary antibodies at RT for 2 h. Again washed thrice in PBST for 10 min each. Tunnel assay is aimed to assess the degree of apoptosis in cells. The sections of STZ control groups showed significant damage accompanied 9 4
with cell apoptosis. However, the PTY 2 treatment for 10 days, significantly prevented this change ( Figure 2 ).
Immunohistochemistry analysis also proved the antiapoptotic effect of PTY 2 on intestinal cells. It significantly reversed the downregulation of 9 6
Bcl 2 expression induced by STZ ( Figure 3 ). PTY 2 recovers the STZ induced stress, as a result the expression of SOD was significantly enhanced. In the other hand, we have also found the 9 9
reduced mRNA expression of stress marker DPP-IV in PTY 2 treated group. This clearly shows the potential of PTY 2 against STZ induced During diabetes, the morphologies and functions of small intestine gets highly altered. Some of this alterations is caused by the oxidative stress Glucagon like peptides plays an important role towards gut adaptation. After their synthesis, they get released into the intestine from the In our previous works, we have already proved PTY 2 as incretin therapeutic agent. It significantly inhibits DPP-IV and enhances the levels of 1 1 5
GLP-1 and GIP. In addition to DPP-IV inhibition, it also act as incretins receptor agonist (Srivastava et al., 2015 (Srivastava et al., , 2017 (Srivastava et al., , 2018a (Srivastava et al., , 2018b . Thus, as 1 1 6
DPP-IV inhibitor, PTY 2 must also enhances the intestinotrophic effect of GLP 2, in addition to GLP-1 and its receptor. . PTY 2 improves the villi count and length, thus enhances the surface area in order to assimilate more nutrients from diet and could also 1 1 9
provide the maximum space for colonization of positive bacteria useful for intestinal health. A detail study is needed to reveal the role of PTY 2 1 2 0 and its individual active constituents in future at both molecular and microbial level against diabetic complications. PTY 2 recovers the STZ induced stress, improves the intestinal morphology, increases the villi number and length as well as prevents apoptosis. As DPP-IV inhibitor, PTY 2 acts as an effective herbal agents for the treatment of intestinal diseases ( Figure 5 ). The data and materials supporting the conclusions of this work are included in the article. The authors, ethical committee, and funding agencies declared no conflict of interest. We are thankful to Prof. Shail Kumar Chaube and his students, Department of Zoology, Institute of Sciences, BHU, for their help in tunnel 1 3 9
assay.
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